Stem cells a step closer
This article was originally published in Clinica
The ebb and flow of the debate surrounding the potential of stem cell research - the ethics, the regulation, the funding - will find its ultimate justification in the proof of its clinical application. The results of two studies, published this week, are being billed as firm steps in this direction.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.